Azumino, Japan

Yusuke Kawabe

This inventor holds 1 USPTO granted patent. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yusuke Kawabe. Retrieved from https://idiyas.com/inventor/yusuke-kawabe-0tvcd7pq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yusuke Kawabe: Innovator in Pharmaceutical Compounds

Introduction

Yusuke Kawabe is a notable inventor based in Azumino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Kawabe holds a patent for hypoxanthine compounds. This invention relates to hypoxanthine compounds or pharmaceutically acceptable salts thereof. The compounds exhibit a prolyl hydroxylase inhibitory effect and are useful as agents for treating inflammatory bowel diseases, such as ulcerative colitis. The patent outlines a method for treating these conditions by administering a pharmaceutical composition containing the hypoxanthine compound or its salts.

Career Highlights

Yusuke Kawabe is associated with Kissei Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical innovations. His work focuses on creating effective treatments for various medical conditions.

Collaborations

Kawabe collaborates with talented colleagues, including Haruka Ohtsuki and Kyosuke Nakamura. Their combined expertise contributes to the innovative environment at Kissei Pharmaceutical.

Conclusion

Yusuke Kawabe's contributions to pharmaceutical science, particularly through his patent on hypoxanthine compounds, highlight his role as an innovator in the field. His work continues to pave the way for advancements in treatments for inflammatory bowel diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…